Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Priapism in Sickle Cell Anemia
source: Family Practice Notebook
year: 2018
summary/abstract:Priapism in Sickle Cell Anemia:
II. Epidemiology
Incidence of Priapism in Sickle Cell Anemia: 89% by age 20 years old
III. Management
Duration: Analgesics
IV Fluids
Do not transfuse for Priapism 4 hours
Administer above measures if not already attempted
Exchange transfusion (Risk of CVA symptoms)
Epidural Anesthesia
+myBinderRelated Content
-
SUSTAIN Clinical Trial Results Show Crizanlizumab Reduced Sickle Cell–Related Pain CrisesResults from the Phase 2 SUSTAIN clinica...
-
Prospective study of sickle cell trait and venous thromboembolism incidenceBACKGROUND: Sickle cell trait may incre...
-
Contrary to expectations: seasonal variation in sickle cell crisis – a nation wide data analysisBackground: Sickle cell crisis is a pain...
-
Shakir Cannon, advocate for minority health, diesShakir Lateef Cannon, a 34-year-old advo...
-
Providing Expert Care for Pregnant Sickle Cell Patienthttps://www.youtube.com/watch?v=rTebitxq...
-
Sickle Cell Treatments can Destroy Germ Cells in Boys, Affecting Fertility in Adulthood, Study SuggestsSome treatments for sickle cell disease ...
-
Sickle Cell Disease and Cold Weather: Dos and Don’tsIn the United States today, one of every...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.